Australia markets close in 1 hour 2 minutes

Microbix Biosystems Inc. (MBXBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.24500.0000 (0.00%)
At close: 11:31AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.2450
Open0.2450
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.2450 - 0.2450
52-week range0.1710 - 0.3530
Volume4,000
Avg. volume5,225
Market cap33.682M
Beta (5Y monthly)0.23
PE ratio (TTM)12.25
EPS (TTM)0.0200
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Microbix Collaborator Introduces New Lab Accreditation Program

    Microbix Product Supporting Testing for Drug-Resistant Sexually-Transmitted InfectionMISSISSAUGA, Ontario, April 25, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that Labquality Ltd., a collaborator and customer, is presenting results of its use of Microbix Quality Assessment Products (“QAPs™”) for accreditation of clinical labs for conducting molecular (“MDx”) tests for antimicrobial-resis

  • GlobeNewswire

    Microbix Presenting at the 2024 Bloom Burton Conference

    MISSISSAUGA, Ontario, April 11, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attending and presenting at the Bloom Burton & Co. Healthcare Investor Conference (the “Conference”) taking place at the Metro Toronto Convention Center, North Building, on April 16 and 17, 2024. The Conference provides an opportunity to connect with Canadian, U.S., and international investors who are in

  • GlobeNewswire

    Microbix Announces Annual and Special Meeting Voting Results

    MISSISSAUGA, Ontario, April 01, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator and exporter, announces the voting results from the Annual and Special Meeting of Shareholders of the Company (the “Meeting”) which was held on March 27, 2024. At the Meeting, 42.64% of the issued and outstanding shares were represented. Shareholders voted in favour of all resolutions brought before the Meeting. Details of all resolut